The Apex Times
Above the Noise
Business Wire
BusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex Times
Back to front
CVS Health wins Newsweek AI Impact Award for pharmacy technology aimed at improving medication instructions
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 9, 9:23 AM EDT

CVS Health wins Newsweek AI Impact Award for pharmacy technology aimed at improving medication instructions

The award highlights CVS Health’s use of artificial intelligence to interpret prescription directions inside pharmacy workflows, an effort designed to reduce manual transcription and improve medication safety and patient care.

By The Apex Times Newsroom3 min readAI-assisted Apex article

CVS Health has been recognized by Newsweek for pharmacy technology that the company says improves medication safety and patient care. The recognition comes as part of the Newsweek 2026 AI Impact Awards, which spotlight real-world uses of artificial intelligence in health care. CVS said it received an award in the AI Health Care category, for “Best Outcomes – Patient Care.”

CVS Health tied the honor to its AI-Driven Prescription Interpretation and Instruction Standardization technology. In CVS’s description, the system uses artificial intelligence embedded directly into pharmacy dispensing workflows across the company’s national pharmacy network. The aim is to help pharmacists and pharmacy technicians better handle electronic prescriptions that may include complex directions for use.

According to CVS, pharmacies often receive prescriptions with detailed instructions that previously required manual transcription by pharmacy teams. CVS said that step creates administrative burden and can limit the time clinicians have available for direct patient support and clinical follow-up.

CVS said it addressed those challenges by deploying trained open-source large language models, or LLMs, to interpret prescription directions. LLMs are AI systems designed to understand and generate language, in this case to read clinical text in prescription instructions and translate it into more usable, standardized directions for dispensing. CVS characterized the approach as responsible, patient-centric automation because it is meant to free clinician time for patient-facing work.

Tony Ambrozie, CVS Health’s Senior Vice President and Chief Digital and Technology Officer, said in the company’s announcement that the recognition reflects CVS’s focus on applying AI in ways that ultimately free up clinicians’ time. He added that embedding intelligent automation into pharmacy workflows gives pharmacists and technicians more time for expert clinical support, which CVS positions as what patients rely on.

CVS did not disclose performance metrics in its announcement, such as how often the system catches potential issues, how much it reduces turnaround time, or whether it has been validated in external studies. The company also did not provide details on which specific types of prescription directions the model handles best, nor how it monitors errors after deployment.

The award comes amid broader industry interest in using AI to reduce administrative tasks in health care. For large pharmacy operators, the dispensing workflow has become a common target for automation because it involves repeated interpretation of clinical instructions at high volume, with clear safety implications when directions are misunderstood or inconsistently entered.

For readers watching this space, the key question is how CVS measures impact beyond recognition. Future disclosures to look for include any published validation results, safety reporting, and operational metrics that show how the technology affects prescribing interpretation quality, pharmacist workload, and patient outcomes in routine pharmacy use.

Why It Matters

  • AI in the dispensing workflow could reduce administrative load, potentially allowing pharmacists to spend more time on direct clinical support.
  • Medication instructions are a safety-critical part of pharmacy care, so improvements in interpretation and standardization may have downstream effects on adherence and outcomes.
  • Industry awards can accelerate adoption, but they do not substitute for independent validation, which may become more important as AI tools scale.

Sources

Key Facts

  • CVS Health was recognized by Newsweek for the 2026 AI Impact Awards in the AI Health Care category for “Best Outcomes – Patient Care.”
  • The company attributed the award to its AI-Driven Prescription Interpretation and Instruction Standardization technology.
  • CVS said the technology embeds AI into pharmacy dispensing workflows across its national pharmacy network.
  • CVS said the tool is designed to interpret complex prescription directions, reducing the need for manual transcription.
  • CVS said it uses trained open-source large language models to interpret clinical directions for use.
  • CVS did not provide performance statistics or study results in the announcement.

Healthcare Related

CVS Health wins Newsweek AI Impact Award for pharmacy technology aimed at improving medication instructions | The Apex Times